Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Illinois Tool Works Inc. (ITW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Illinois Tool Works Inc. — how do they compare? Definium Therapeutics Inc. Common Shares trades at $37.01 (market cap $4.59B), while Illinois Tool Works Inc. trades at $262 (market cap $74.38B). The key difference: Illinois Tool Works Inc. is far larger — about 16.2× Definium Therapeutics Inc. Common Shares's market cap, and Illinois Tool Works Inc. pays a 2.63% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Illinois Tool Works Inc. for 67 Days on average.
| DFTX | ITW | |
|---|---|---|
Market Cap | $4.59B | $74.38B |
Volume | 2,103,937 | 1,125,477 |
Sector | Health | Industrials |
52-Week High | $48.45 | $299.60 |
52-Week Low | $10.68 | $241.07 |
Typical Hold Time | 0 Days | 67 Days |
Enterprise Value | $3.55B | $83.23B |
Dividend Yield | — | 2.63% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
ITW trades at $261.15, down 2.24% on the day, with technical indicators showing bearish momentum as the stock tests support near $261. The company maintains strong fundamentals with a 19.39% net income margin and has beaten earnings estimates for three consecutive quarters. Recent news highlights ITW's dividend increase to $1.72 per share, reinforcing its status as a Dividend King with 59 years of consecutive increases.
The outlook remains mixed with solid profitability offset by bearish technicals. Upside potential exists toward the $276.86 analyst consensus target, but investors face headwinds from weak technical momentum and mixed analyst sentiment where only 21% recommend buying. Key risks include debt levels rising to 55.54% of assets and exposure to cyclical industrial demand.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Illinois Tool Works Inc.
Illinois Tool Works is a diversified global manufacturer that produces specialized industrial equipment, consumables, and related services. The firm operates 87 global divisions through seven distinct operating segments: automotive OEM, construction products, food equipment, specialty products, test/measurement and electronics, polymers and fluids, and welding. About half of its revenue comes from its operations in North America, with the remainder originating from international markets. ITW takes a bottom-up and decentralized approach to portfolio management, with the exception that each segment must apply its 80/20 operating process modeled on the Pareto principle.
Read more on ITW →
